FES - FES proto-oncogene, tyrosine kinase Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 609483
FES Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_038661389.1 | XP_038517317.1 | tyrosine-protein kinase Fes/Fps |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tyrosine-protein kinase Fes/Fps |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(10)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0988 | Deferoxamine mesylate | 99.86% | Unkown | |
| HY-B1625 | Deferoxamine | 99.76% | Yes | |
| HY-16168A | Degarelix | 99.96% | Unkown | |
| HY-107928 | Iron dextran | / | Unkown | |
| HY-B1306 | 4-Aminohippuric acid | 99.84% | Unkown | |
| HY-16564 | Deferasirox (Fe3+ chelate) | Inhibitor | 98.0% | Unkown |
| HY-108017 | Ferric maltol | 99.93% | Unkown | |
| HY-16168 | Degarelix acetate | Antagonist | 99.67% | Unkown |
| HY-16168B | Degarelix acetate hydrate | / | Unkown | |
| HY-17609C | Difelikefalin acetate | Agonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-12040 | Elesclomol | 99.43% | Phase 3 | |
| HY-P1714 | Apraglutide | 99.90% | Phase 3 | |
| HY-105239 | Selepressin | Agonist | 98.17% | Phase 3 |
| HY-105239A | Selepressin acetate | Agonist | 98.04% | Phase 3 |
| HY-P1714A | Apraglutide TFA | 98.69% | Phase 3 | |
| HY-122844 | Ifebemtinib | Inhibitor | 99.86% | Phase 2 |
| HY-P3516 | Barusiban | Antagonist | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(168)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-D1533 | RhoNox-1 | 98.54% | Unkown | |
| HY-W004544 | o-Phenanthroline | Inhibitor | 99.96% | Unkown |
| HY-D1913 | Fe2Orange | 98.2% | Unkown | |
| HY-137805 | Ferrozine | 99.96% | Unkown | |
| HY-N0928 | Mimosine | Inducer | 99.97% | Unkown |
| HY-128525 | Enterobactin | Inhibitor | 99.64% | Unkown |
| HY-W075707 | FeTCPP chloride | 95.0% | Unkown | |
| HY-145157 | Ferric nitrilotriacetate | 98.0% | Unkown | |
| HY-N10473 | Pulcherriminic acid | Inhibitor | 98.0% | Unkown |
| HY-D2295 | Mito-FerroGreen | 97.30% | Unkown | |
| HY-D0221 | 2,4,6-Tri-2-pyridinyl-1,3,5-triazine | 99.87% | Unkown | |
| HY-Y1841 | o-Phenanthroline monohydrate | Inhibitor | 99.95% | Unkown |
| HY-126823 | Phen Green SK diacetate (5/6-mixture) | 92.99% | Unkown | |
| HY-163897 | PROTAC NCOA4 degrader-1 | Inhibitor | 99.75% | Unkown |
| HY-N10470 | Bleomycin A5 | 99.81% | Unkown | |
| HY-P3267A | Apo-Bovine Transferrin | Activator | 95.2% | Unkown |
| HY-132989 | Mal-Deferoxamine | 95.0% | Unkown | |
| HY-156418 | KY386 | 99.86% | Unkown | |
| HY-D0945 | Xylene Cyanol FF | 94.69% | Unkown | |
| HY-107928B | Iron–Dextran(Fe 35-40% w/w) | / | Unkown | |
| HY-W010323 | 2,5-Dihydroxy-1,4-benzoquinone | Inhibitor | 99.95% | Unkown |
| HY-W015600 | 2-Acetamidophenol | 99.73% | Unkown | |
| HY-W075508 | MIL-100(Fe) | ≥98.0% | Unkown | |
| HY-158739 | Rhodamine dithenoyl hydrazide | 98.00% | Unkown | |
| HY-DY1030 | RhoNox-1 (solution) | / | Unkown | |
| HY-158779 | Sulfane sulfur probe 4 | 97.3% | Unkown | |
| HY-Y1422I | Lipase,Pseudomonas fluorescens (Immobilized) | / | Unkown | |
| HY-D2339 | H-FluNox | 99.53% | Unkown | |
| HY-W698249 | Ferrous gluconate | 99.25% | Unkown | |
| HY-160238 | Bacillibactin | Inhibitor | 98.1% | Unkown |
| HY-Y0102 | Thiosalicylic acid | 99.28% | Unkown | |
| HY-136300 | PHD-1-IN-1 | Inhibitor | 99.21% | Unkown |
| HY-W019888 | Iron(II) chloride | 99.99% | Unkown | |
| HY-W151629A | Ferrozine sodium hydrate | 99.80% | Unkown | |
| HY-145286 | IMPDH2-IN-2 | 99.89% | Unkown | |
| HY-178364 | GPX4-IN-19 | 99.45% | Unkown | |
| HY-B1250 | Acedoben | 99.68% | Unkown | |
| HY-P2777 | Ceruloplasmin | / | Unkown | |
| HY-W067445 | N-(4-Formylphenyl)acetamide | 99.68% | Unkown | |
| HY-B1159S | Nitroxoline-d4 | 99.7% | Unkown | |
| HY-B1250A | Acedoben sodium | 99.99% | Unkown | |
| HY-N0046 | Notoginsenoside Fe | Inhibitor | 99.99% | Unkown |
| HY-W011816 | 1,2-Hexadecanediol | 99.94% | Unkown | |
| HY-W015600S | 2-Acetamidophenol-d3 | 99.48% | Unkown | |
| HY-W134005 | Mg(Ⅱ)-EDTA disodium tetrahydrate | 99.16% | Unkown | |
| HY-W112939 | Fe(III)(TDCPP) chloride | 95.00% | Unkown | |
| HY-155539 | Cisd2 agonist 2 | Agonist | 99.17% | Unkown |
| HY-156776 | HAPSBC | ≥95.0% | Unkown | |
| HY-W249602 | MIL-88A(Fe) | / | Unkown | |
| HY-N18050 | Petrobactin | / | Unkown | |
| HY-160414 | TRX-COBI | Inhibitor | / | Unkown |
| HY-B1306S | 4-Aminohippuric acid-d4 | 98.6% | Unkown | |
| HY-D3116 | RhoNox-4 | Inhibitor | 98.55% | Unkown |
| HY-W107177 | 5,10,15,20-tetrakis(p-chlorophenyl)porphyrin iron(III) chloride | 95.00% | Unkown | |
| HY-W112021 | 2,5-DMBQ | 99.99% | Unkown | |
| HY-W113011 | 5,10,15,20-Tetra(4-methylphenyl)-21H,23H-porphine iron(III) chloride | / | Unkown | |
| HY-W124354 | MIL-101-Fe | / | Unkown | |
| HY-W718262 | Dihydroaeruginoic acid | / | Unkown | |
| HY-Y1422E | Lipase,Aspergillusniger (Immobilized) | / | Unkown | |
| HY-N13871 | Anguibactin | Inhibitor | / | Unkown |
| HY-125918 | Bleomycin A5 hydrochloride | / | Unkown | |
| HY-100332 | CP 375 | / | Unkown | |
| HY-115832 | Ap44mSe | / | Unkown | |
| HY-117478 | FE-999024 | Inhibitor | / | Unkown |
| HY-117710B | AD-35 | Inhibitor | / | Unkown |
| HY-12040S | Elesclomol-d2 | / | Unkown | |
| HY-133849 | Aristoforin | Inhibitor | / | Unkown |
| HY-138185 | Collismycin A | Inhibitor | / | Unkown |
| HY-143249 | MtMetAP1-IN-1 | Inhibitor | / | Unkown |
| HY-149151 | Variegatic acid | Inhibitor | / | Unkown |
| HY-149418 | BChE/HDAC6-IN-2 | Inhibitor | / | Unkown |
| HY-155158 | Anticancer agent 147 | Inducer | / | Unkown |
| HY-157917 | Nitro-PAPS disodium dihydrate | / | Unkown | |
| HY-157926 | Nitroso-PSAP | / | Unkown | |
| HY-159943 | ROS151 | Inhibitor | / | Unkown |
| HY-16168AS | Degarelix-d7 | Antagonist | / | Unkown |
| HY-16168AS1 | Degarelix-d7 TFA | / | Unkown | |
| HY-16168AS2 | Degarelix-d7 TFA-1 | / | Unkown | |
| HY-162812 | H3R antagonist 4 | Inhibitor | / | Unkown |
| HY-162933 | AChE-IN-77 | Inhibitor | / | Unkown |
| HY-165381 | ZMC2 | Inducer | / | Unkown |
| HY-170433 | DefNEtTrp | Inducer | / | Unkown |
| HY-172092 | BG11 | Inducer | / | Unkown |
| HY-174867 | AY-4 | Agonist | / | Unkown |
| HY-175698 | Ferroptosis inducer-9 | / | Unkown | |
| HY-175852 | Ferroptosis inducer-11 | / | Unkown | |
| HY-176212 | Ferroptosis-IN-20 | Inhibitor | / | Unkown |
| HY-17655 | TBE56 | Inhibitor | / | Unkown |
| HY-177506 | FE100726 | Agonist | / | Unkown |
| HY-177507 | FE101120 | Agonist | / | Unkown |
| HY-178370 | Ferroptosis inducer-12 | Inducer | 96.32% | Unkown |
| HY-179003 | mTOR/GLS1-IN-1 | / | Unkown | |
| HY-179016 | Ferroptosis/apoptosis inducer-3 | / | Unkown | |
| HY-180114 | NSS-18 | / | Unkown | |
| HY-181982 | HJ03 | / | Unkown | |
| HY-182300 | FE 999011 | / | Unkown | |
| HY-182578 | Mimosinamine | Inhibitor | / | Unkown |
| HY-183618 | DW-229 | Degrader | / | Unkown |
| HY-183760 | AChE/BChE-IN-37 | Inhibitor | / | Unkown |
| HY-186106 | 3-Deoxyanguibactin | / | Unkown | |
| HY-186239 | Azophloxine-1,7-disulfonate disodium | / | Unkown | |
| HY-D2204 | SHP1-IN-1 | Inhibitor | / | Unkown |
| HY-D2730 | N14G-Fe | Inhibitor | / | Unkown |
| HY-D3377 | HMRhoNox-M | / | Unkown | |
| HY-DY1106 | Ferrozine (solution) | / | Unkown | |
| HY-E70311 | 1,3-specific lipase,Bacillus lanolin (Immobilized) | / | Unkown | |
| HY-E70583 | Recombinant Ten-Eleven Translocase | / | Unkown | |
| HY-E70905 | Taurine Dioxygenase, E. coli | / | Unkown | |
| HY-E71077 | (5R)-Carbapenem-3-carboxylate synthase | / | Unkown | |
| HY-E71089 | (R)-2-Methylmalate dehydratase | / | Unkown | |
| HY-E71099 | (R)-Dichlorprop dioxygenase 2-oxoglutarate | / | Unkown | |
| HY-E71143 | 1,2-Dihydroxynaphthalene dioxygenase | / | Unkown | |
| HY-E71221 | α-D-Ribose 1-methylphosphonate 5-phosphate C-P-lyase | / | Unkown | |
| HY-E71278 | β-Carotene 15,15'-dioxygenase | / | Unkown | |
| HY-E71279 | β-Carotene 3-hydroxylase | / | Unkown | |
| HY-E71332 | γ-Butyrobetaine dioxygenase | / | Unkown | |
| HY-E71337 | γ-Glutamyl hercynylcysteine S-oxide synthase | / | Unkown | |
| HY-N17362 | Anhydroevoxine | / | Unkown | |
| HY-P11424 | Cyclo(GRGDSPA) | Inhibitor | / | Unkown |
| HY-P11504 | Fmoc-Lys-Gly-Dopa-OH | / | Unkown | |
| HY-RS04867 | FES Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W004544S | o-Phenanthroline-d8 | Inhibitor | / | Unkown |
| HY-W075620 | NH2-MIL-88B(Fe) | / | Unkown | |
| HY-W075622 | NH2-MIL-53(Fe) | / | Unkown | |
| HY-W075623 | NH2-MIL-101(Fe) | / | Unkown | |
| HY-W075625 | MIL-88B(Fe) | / | Unkown | |
| HY-W075630 | Mil-53(Fe) | / | Unkown | |
| HY-W249563 | PCN-250(Fe2Co) | / | Unkown | |
| HY-W249605 | PCN-222 | / | Unkown | |
| HY-W414357 | 2-Aminophenanthrene | / | Unkown | |
| HY-W698271 | Ferrous lactate trihydrate | / | Unkown | |
| HY-W747297 | β-Selinene | Inhibitor | / | Unkown |
| HY-W747910A | S584 dihydrochloride | / | Unkown | |
| HY-138075 | Obafluorin | Inhibitor | 99.9% | Unkown |
| HY-148340 | 24RBPyBC | / | Unkown | |
| HY-153217 | Arsonic acid | / | Unkown | |
| HY-153512 | PHD-1-IN-3 | Inhibitor | / | Unkown |
| HY-17609S | Difelikefalin-d5 | Agonist | / | Unkown |
| HY-179102 | SARS-CoV-2 Mpro-IN-51 | Inhibitor | / | Unkown |
| HY-180223 | FXIa-IN-17 | Inhibitor | / | Unkown |
| HY-184620 | Fe3O4 nanoparticle | / | Unkown | |
| HY-184625 | PEI coated Fe3O4 nanoparticles | / | Unkown | |
| HY-184627 | Carboxylated dextran coated Fe3O4 nanoparticles | / | Unkown | |
| HY-184629 | Ultra small magnetic Fe3O4 nanoparticles | / | Unkown | |
| HY-184630 | PLL coated Fe3O4 nanoparticles | / | Unkown | |
| HY-184631 | Carboxymethyldextran modified Fe3O4 nanoparticles | / | Unkown | |
| HY-184632 | Fe3O4 nanorods | / | Unkown | |
| HY-184633 | Hollow mesoporous Fe3O4 nanoparticles | / | Unkown | |
| HY-184634 | OA Coated Fe3O4 Nanoparticles | / | Unkown | |
| HY-184635 | Monodisperse Fe3O4 microspheres | / | Unkown | |
| HY-184636 | PLL coated Fe2O3 nanoparticles | / | Unkown | |
| HY-184637 | DMSA Coated Fe2O3 Nanoparticles | / | Unkown | |
| HY-184638 | APTS Fe2O3 Nanoparticles | / | Unkown | |
| HY-184639 | Carboxylated magnetic microspheres (low non-specificity) | / | Unkown | |
| HY-184640 | Carboxylated magnetic microspheres | / | Unkown | |
| HY-184643 | Mn-Zn Ferrite Nanoparticles | / | Unkown | |
| HY-184647 | Citrate-modified ferric oxide nanoparticles | / | Unkown | |
| HY-185401 | ATSM | / | Unkown | |
| HY-N14059 | Halymecin B | / | Unkown | |
| HY-N14060 | Halymecin C | / | Unkown | |
| HY-N15282 | Broussoflavonol G | / | Unkown | |
| HY-RS18447 | Fes Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24929 | Fes Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008952 | Tributyltetradecyl phosphonium chloride | / | Unkown | |
| HY-W009022 | Diantipyrylmethane | 98.98% | Unkown | |
| HY-W094110 | Iron(III) sulfate | / | Unkown | |
| HY-W130303 | Diacetamide | / | Unkown | |
| HY-W722245 | Pyochelin | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service